Handheld device holds promise for onsite cancer diagnosis

09/7/2011 | PBS

Researchers at Michigan State University and the University of Michigan have created a handheld device called Gene-Z that they say could aid in cancer diagnosis in underserved areas. The device, which features a microfluidic chip, allows providers to analyze blood samples onsite and transmits the readings to an Android tablet, iPad or iPod Touch.

View Full Article in:

PBS

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Food & Drug Associate
Confidential
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA